Sepsis Management Guidelines

Initial Assessment and Resuscitation

The Society of Critical Care Medicine recommends performing a thorough clinical examination to identify the source of infection, including evaluation of physiologic variables such as heart rate, blood pressure, arterial oxygen saturation, respiratory rate, temperature, and urine output 1, 2
The European Society of Intensive Care Medicine suggests beginning immediate resuscitation for patients with sepsis-induced hypoperfusion (defined by hypotension or elevated lactate levels) 1, 3
Administer at least 30 mL/kg of IV crystalloid fluid within the first 3 hours for patients with sepsis-induced hypoperfusion, as recommended by the Surviving Sepsis Campaign 3, 2
Target a mean arterial pressure of 65 mmHg in patients requiring vasopressors, according to the American College of Critical Care Medicine 1, 2
Measure lactate levels at the time of sepsis diagnosis and repeat within 6 hours after initial fluid resuscitation if initially elevated, as suggested by the Society of Critical Care Medicine 2

Microbiological Diagnosis

Obtain appropriate routine microbiologic cultures before starting antimicrobial therapy (if no significant delay >45 minutes), as recommended by the Infectious Diseases Society of America 3, 2
Collect at least two sets of blood cultures (both aerobic and anaerobic bottles), according to the Centers for Disease Control and Prevention 3
Sample fluid or tissue from the suspected site of infection whenever possible, as suggested by the European Society of Clinical Microbiology and Infectious Diseases 4
Examine sampled fluid or tissue by Gram stain, culture, and whenever possible by antibiogram, according to the American Society for Microbiology 4

Antimicrobial Therapy

Administer IV antimicrobials as soon as possible after recognition and within one hour for both sepsis and septic shock, as recommended by the Surviving Sepsis Campaign 2, 5
Use empiric broad-spectrum therapy with one or more antimicrobials to cover all likely pathogens (including bacterial and potentially fungal or viral coverage), according to the Infectious Diseases Society of America 5, 2
Plan to narrow antimicrobial therapy once pathogen identification and sensitivities are established and/or adequate clinical improvement is noted, as suggested by the Society of Critical Care Medicine 5

Source Control

Identify or exclude a specific anatomic diagnosis of infection requiring emergent source control as rapidly as possible, according to the American College of Surgeons 2
Implement required source control interventions (drainage or debridement) as soon as medically and logistically practical, as recommended by the Infectious Diseases Society of America 4, 2
Remove any foreign body or device that may potentially be the source of infection, according to the Centers for Disease Control and Prevention 4

Hemodynamic Support

Use norepinephrine as the first-choice vasopressor for patients with persistent hypotension despite adequate fluid resuscitation, as recommended by the Society of Critical Care Medicine 2
Consider epinephrine or dopamine when an additional agent is needed to maintain adequate blood pressure, according to the American College of Critical Care Medicine 4, 2
In patients requiring vasopressors, measure arterial blood pressure and heart rate frequently, as suggested by the European Society of Intensive Care Medicine 4

Oxygenation and Ventilation

Apply oxygen to achieve an oxygen saturation >90%, according to the American Thoracic Society 4
Place patients in a semi-recumbent position (head of the bed raised to 30-45°), as recommended by the Society of Critical Care Medicine 4
Consider non-invasive ventilation in patients with dyspnea and/or persistent hypoxemia despite oxygen therapy if medical staff is adequately trained, according to the American College of Chest Physicians 4

Ongoing Monitoring

Monitor for signs of adequate tissue perfusion, including capillary refill time, skin mottling, temperature of extremities, peripheral pulses, mental status, and urine output, as suggested by the European Society of Intensive Care Medicine 4
Reassess the patient frequently to evaluate response to treatment and need for escalation of care, according to the Society of Critical Care Medicine 2
Guide resuscitation to normalize lactate in patients with elevated lactate levels as a marker of tissue hypoperfusion, as recommended by the Surviving Sepsis Campaign 1, 2

Sepsis Management Guidelines

Initial Resuscitation and Recognition

The Society of Critical Care Medicine recommends recognizing sepsis as a medical emergency requiring immediate action, with administration of at least 30 mL/kg IV crystalloid within the first 3 hours for sepsis-induced hypoperfusion 6
Calculate NEWS2 score if available to standardize risk assessment, as recommended by the British Medical Journal 7
Administer IV broad-spectrum antimicrobials within 1 hour of recognizing sepsis or septic shock, with each hour of delay decreasing survival by 7.6%, according to the Intensive Care Medicine journal 6, 8

Antimicrobial Therapy

The Intensive Care Medicine journal recommends reassessing antimicrobial therapy daily for potential de-escalation once pathogen identification and sensitivities are established, and narrowing to the most appropriate single therapy based on culture results and clinical improvement 6, 9, 8
Plan for 7-10 days of antimicrobial therapy for most serious infections associated with sepsis, as recommended by the Intensive Care Medicine journal 6, 8

Hemodynamic Support

Target mean arterial pressure (MAP) ≥65 mmHg as the primary hemodynamic goal, according to the Intensive Care Medicine journal 6
Measure lactate levels immediately at sepsis recognition, and repeat lactate measurement within 6 hours after initial fluid resuscitation if initially elevated, guiding resuscitation to normalize lactate as a marker of tissue hypoperfusion 6

Vasopressor Support

Initiate norepinephrine as the first-choice vasopressor if hypotension persists despite adequate fluid resuscitation, and add epinephrine when an additional agent is needed to maintain adequate blood pressure, as recommended by the Critical Care Medicine journal 10
Vasopressin (0.03 U/min) can be added to norepinephrine to raise MAP or decrease norepinephrine dose, but should not be used as the initial vasopressor, according to the Critical Care Medicine journal 10

Adjunctive Therapies

Avoid routine use of IV hydrocortisone in septic shock patients if adequate fluid resuscitation and vasopressor therapy restore hemodynamic stability, as recommended by the Critical Care Medicine journal 10
Target hemoglobin 7-9 g/dL in the absence of tissue hypoperfusion, ischemic coronary artery disease, or acute hemorrhage, according to the Critical Care Medicine journal 10

Prophylaxis

Provide deep vein thrombosis prophylaxis with pharmacologic agents unless contraindicated, and use stress ulcer prophylaxis (H2 blockers or proton pump inhibitors) in patients with bleeding risk factors, as recommended by the Critical Care Medicine journal 10

Goals of Care Discussion

Discuss goals of care and prognosis with patients and families, incorporating these into treatment planning using palliative care principles where appropriate, as recommended by the Intensive Care Medicine journal 6
Address goals of care as early as feasible, but no later than within 72 hours of ICU admission, according to the Intensive Care Medicine journal 6

Discharge Planning

Complete the planned antimicrobial course (typically 7-10 days total) with transition to oral agents when clinically appropriate, as recommended by the Intensive Care Medicine journal 6, 8
Provide clear instructions on antimicrobial duration, dosing, and potential adverse effects, according to the Intensive Care Medicine journal 8

Initial Management of Septic Shock Secondary to Urinary Tract Infection

Empiric Antimicrobial Therapy

Initiate broad‑spectrum intravenous antibiotics within 60 minutes of septic shock recognition; each hour of delay reduces survival by ≈ 7.6 %【11】.
For hypotensive urinary‑tract infections, use empiric regimens that cover typical uropathogens such as meropenem, imipenem‑cilastatin, or piperacillin‑tazobactam【11】.

Vasopressor Strategy

Norepinephrine is the first‑line vasopressor, dosed at 0.1–1.3 µg·kg⁻¹·min⁻¹【11】.

Hemodynamic Targets (first 6 hours)

Central venous pressure (CVP) target of 8–12 mm Hg【11】.
Central venous oxygen saturation (ScvO₂) target of ≥ 70 %【11】.

Initial Management of Septic Shock in Adults

Fluid Resuscitation

Administer at least 30 mL/kg of intravenous crystalloid within the first 3 hours of septic shock recognition. 12
Use crystalloids (normal saline or balanced solutions) as the first‑line fluid choice for volume replacement. 12 13
Avoid hydroxyethyl starch formulations because they increase the risk of acute kidney injury and mortality. 12 14

Antimicrobial Therapy

Give broad‑spectrum intravenous antibiotics within 1 hour of septic shock identification; this is the most time‑critical intervention. 12 15
Obtain at least two sets of blood cultures (aerobic and anaerobic) before starting antibiotics, but do not delay antibiotics more than 45 minutes to obtain cultures. 12 15
Choose empiric therapy that covers all likely pathogens (including fungi when indicated) and achieves good tissue penetration at the presumed infection source. 12 15

Hemodynamic Targets (First 6 Hours)

Target a mean arterial pressure (MAP) ≥ 65 mmHg. 12 13
Maintain a central venous pressure (CVP) of 8–12 mmHg. 12 15
Ensure urine output ≥ 0.5 mL/kg/h. 12 15
Aim for a central venous oxygen saturation (ScvO₂) ≥ 70 % or a mixed venous O₂ saturation ≥ 65 %. 12 15

Lactate Monitoring

Measure serum lactate immediately at septic shock recognition. 15
Use lactate normalization as a resuscitation endpoint to indicate resolution of tissue hypoperfusion. 15

Vasopressor Support

Norepinephrine is the first‑line vasopressor for persistent hypotension after adequate fluid resuscitation; start at 0.05–0.1 µg/kg/min and titrate to maintain MAP ≥ 65 mmHg. 12 13
Epinephrine may be added when an additional agent is needed to achieve target MAP. 12 13
Vasopressin (0.03 U/min) can be added to norepinephrine to raise MAP or reduce norepinephrine dose, but it should not be used as the initial vasopressor. 12 13
Avoid dopamine except in highly selected patients (e.g., low risk of tachyarrhythmias, bradycardia). 12 13
Dobutamine should be added when myocardial dysfunction or ongoing hypoperfusion persists despite adequate volume status and MAP. 12 13

Source Control

Identify or exclude a specific anatomic source that requires emergent control within 12 hours of septic shock onset. 15
Perform required source‑control interventions (drainage, debridement, device removal) as soon as medically and logistically feasible. 15
Obtain prompt imaging to confirm the suspected infection source. 12 15

Antimicrobial De‑escalation

Reassess antimicrobial therapy daily once pathogen identification and susceptibilities are available, with the goal of de‑escalation. 12 15
Narrow to the most appropriate single agent based on culture results and clinical improvement. 15
Plan a total antibiotic course of 7–10 days for most serious infections; extend duration for slow response, undrained foci, Staphylococcus aureus bacteremia, or immunodeficiency. 12 15

Adjunctive Therapies

Corticosteroids

Do not use routine IV hydrocortisone in adult septic shock patients who achieve hemodynamic stability with fluids and vasopressors. 12 14
Consider hydrocortisone 200 mg/day if hemodynamic stability cannot be attained despite adequate resuscitation. 14

Blood Product Management

Target a hemoglobin level of 7–9 g/dL unless there is tissue hypoperfusion, ischemic coronary disease, or acute hemorrhage. 12 13 14
Platelet transfusion thresholds: <10,000 /mm³ (no bleeding), <20,000 /mm³ (significant bleeding risk), ≥50,000 /mm³ (active bleeding or invasive procedures). 14

Prophylaxis

Provide pharmacologic deep‑vein thrombosis prophylaxis unless contraindicated. 12 13
Use stress‑ulcer prophylaxis (H₂‑blocker or proton‑pump inhibitor) in patients with bleeding risk factors. 12 13

Mechanical Ventilation (When Required)

For sepsis‑induced ARDS, set a tidal volume of 6 mL/kg predicted body weight. 12 14
Keep plateau pressures ≤ 30 cm H₂O in passively inflated lungs. 12 14
Apply positive end‑expiratory pressure (PEEP) to prevent alveolar collapse. 14
Maintain head‑of‑bed elevation of 30–45° to reduce ventilator‑associated pneumonia risk. 12 14

Ongoing Monitoring & Goals of Care

Address goals of care early, ideally within the first 72 hours of ICU admission. 12

Mean Arterial Pressure Targets and Fluid/Vasopressor Management for ICU Hypotension

Initial Fluid Resuscitation

Give at least 30 mL/kg of intravenous crystalloid within the first 3 hours to patients with hypotension and suspected tissue hypoperfusion. This early bolus is the cornerstone of resuscitation and should be started promptly. [16][17]
Use isotonic crystalloid solutions (normal saline or balanced fluids) as first‑line therapy because they are well‑tolerated, inexpensive, and have comparable efficacy to other resuscitation fluids. [16][18]
Continue fluid administration while hemodynamic improvement is observed, using dynamic indices (e.g., pulse‑pressure variation, stroke‑volume variation) or static variables (arterial pressure, heart rate) to guide ongoing therapy. 17
Avoid excessive fluid in patients with generalized peritonitis or at risk for abdominal compartment syndrome; fluid overload can worsen gut edema, raise intra‑abdominal pressure, and precipitate respiratory compromise. [16][18]

Vasopressor Initiation and Choice

Start vasopressor therapy when MAP remains < 65 mmHg after adequate fluid resuscitation, or emergently in severe shock (e.g., critically low diastolic pressure) even before fluids are complete. [17][19]
Norepinephrine is the first‑line vasopressor for ICU hypotension, especially septic shock. It provides reliable MAP elevation with a favorable safety profile. [16][17]18
Initial norepinephrine dose: 0.05–0.1 µg/kg/min, titrated to maintain MAP ≥ 65 mmHg. 17
Norepinephrine is more effective than dopamine for reversing hypotension and is associated with fewer arrhythmias. [16][18]
Peripheral administration of norepinephrine is acceptable initially to avoid delays while central venous access is obtained. 19
If additional MAP support is needed, add vasopressin (0.03 U/min) to norepinephrine to raise MAP or to permit a lower norepinephrine dose. Vasopressin should never be used as the sole initial agent and carries a higher risk of digital ischemia. [17][19]
Epinephrine may be used as a second‑line agent when norepinephrine alone is insufficient. 17

MAP Target Selection

A MAP target of ≥ 65 mmHg is appropriate for most critically ill adults; below this threshold organ autoregulation fails and blood flow becomes pressure‑dependent. [16][17][18][19]
For patients with chronic hypertension, a higher MAP (70–85 mmHg) may be required because their autoregulatory curve is shifted rightward. 19
Patients with cirrhosis should maintain MAP > 65 mmHg, as ICU mortality rises when MAP falls below this level. 19

Monitoring Beyond MAP

MAP alone does not guarantee adequate tissue perfusion; it must be supplemented with additional bedside markers.
- Serum lactate: obtain an initial value and repeat within 6 hours if elevated; use trends to guide resuscitation toward normalization. 16
- Urine output: aim for ≥ 0.5 mL/kg/h as an indicator of renal perfusion. 17
- Mental status: regular neurologic checks to assess cerebral perfusion. 17
- Skin perfusion / capillary refill: target refill ≤ 2 seconds to reflect peripheral perfusion. 17

Practical Management Algorithm (Condensed)

Recognize hypotension (MAP < 65 mmHg) and evaluate for tissue hypoperfusion using lactate, urine output, mental status, and skin perfusion. [16][17]
Administer 30 mL/kg IV crystalloid within the first 3 hours. [16][17]
Re‑assess hemodynamics after the fluid bolus with dynamic or static measures. 17
If MAP remains < 65 mmHg despite adequate fluids, start norepinephrine at 0.05–0.1 µg/kg/min (peripheral line acceptable). [17][19]
Titrate norepinephrine to achieve MAP ≥ 65 mmHg (or higher for chronic hypertension, lower for very elderly patients). [17][19]
If further MAP support is required, add vasopressin 0.03 U/min or consider epinephrine. [17][19]
Continuously monitor tissue‑perfusion markers (serial lactate every 2–6 h, urine output, neurologic status, capillary refill). 17

Common Pitfalls to Avoid

Do not rely solely on MAP; normal MAP can coexist with severe tissue hypoperfusion (“cold shock”). 17
Do not assume a universal MAP = 65 mmHg target; adjust upward for chronic hypertension or intra‑abdominal hypertension, and consider lower targets in the very elderly. 19
Avoid fluid overload, especially in patients with peritonitis or at risk for abdominal compartment syndrome. [16][18]
Do not use dopamine as first‑line therapy; it is linked to more arrhythmias and worse outcomes compared with norepinephrine. [16][18]

First‑Hour Bundle for Septic Shock Management

Antimicrobial Therapy

The Surviving Sepsis Campaign recommends that, within the first hour of septic shock recognition, broad‑spectrum intravenous antibiotics be administered and the regimen must cover gram‑positive, gram‑negative, and anaerobic organisms, adding antifungal agents when risk factors such as immunosuppression or prolonged ICU stay are present【20】【21】.
The same guideline stresses the importance of achieving adequate tissue penetration by using appropriate dosing strategies for the chosen agents【20】【21】.

Fluid Resuscitation

The Surviving Sepsis Campaign advises giving at least 30 mL kg⁻¹ of isotonic crystalloid (normal saline or balanced solution) within the first 3 hours of septic shock as a minimum target; larger volumes may be required if hemodynamic response persists【20】.
Hydroxyethyl starches should be avoided because they increase the risk of acute kidney injury and mortality; isotonic crystalloids are the preferred first‑line fluid【20】.
Ongoing fluid administration should be guided by dynamic indices (e.g., pulse‑pressure variation, stroke‑volume variation) and static variables (arterial pressure, heart rate) to ensure continued hemodynamic improvement【20】.

Vasopressor Support

When mean arterial pressure (MAP) remains < 65 mmHg despite adequate fluid resuscitation, norepinephrine is the first‑choice vasopressor according to the Surviving Sepsis Campaign【20】.
Epinephrine may be added as a second‑line agent if norepinephrine alone does not achieve the MAP target【20】.

Source Control

The guideline requires identification—or exclusion—of a specific anatomic focus that needs emergent source control within 12 hours of septic shock onset【20】【22】.
Required interventions (e.g., drainage, debridement, removal of infected devices) should be performed as soon as medically and logistically feasible【20】【22】.
The least physiologically invasive effective method should be chosen, such as percutaneous drainage rather than open surgery when appropriate【20】【22】.
Intravascular access devices that may be the infection source should be removed promptly after alternative access is secured【20】【22】.
An exception is infected peripancreatic necrosis, where definitive intervention is delayed until viable and non‑viable tissue can be clearly demarcated【20】【22】.

Hemodynamic Targets (First 6 Hours)

Maintain MAP ≥ 65 mmHg; consider higher targets (70–85 mmHg) in patients with chronic hypertension【20】.
Aim for a central venous pressure of 8–12 mmHg (or 12–15 mmHg if the patient is mechanically ventilated)【23】.
Target central venous oxygen saturation (ScvO₂) ≥ 70 % (or mixed venous O₂ saturation ≥ 65 %) to ensure adequate tissue oxygen delivery【23】.

Antimicrobial Stewardship

Daily reassessment of antimicrobial therapy is recommended once pathogen identification and susceptibility results are available【20】.
De‑escalation to the most appropriate single agent should occur within 3–5 days based on culture data and clinical response【20】【23】.
The total duration of therapy for most serious infections associated with septic shock should be 7–10 days【20】【23】; longer courses are advised for slow clinical response, undrained foci, Staphylococcus aureus bacteremia, fungal/viral infections, or immunodeficiency (e.g., neutropenia)【20】【23】.
Procalcitonin levels may be used to support shortening the antimicrobial course or discontinuing empiric therapy when evidence of infection is limited【20】.

Initial Management of Adult Sepsis (Cited Recommendations)

Fluid Resuscitation

Hemodynamic Targets (First 6 Hours)

Vasopressor Therapy (When Fluids Insufficient)

Source Control

Mechanical Ventilation for Sepsis‑Associated ARDS

Hemodynamic Management in Septic Shock

Fluid Resuscitation (First 3 Hours)

Administer at least 30 mL/kg of intravenous crystalloid (normal saline or balanced solution) within the first three hours of septic‑shock recognition, and continue additional fluids while hemodynamic improvement is observed, guided by dynamic (e.g., pulse‑pressure variation) or static (e.g., urine output, mental status) indices. 26

Hemodynamic Targets (First 6 Hours)

Aim for a mean arterial pressure (MAP) ≥ 65 mmHg in most adult patients to prevent pressure‑dependent organ hypoperfusion. 26
Maintain urine output ≥ 0.5 mL/kg/hour as a bedside marker of adequate renal perfusion. 26
Target a central venous pressure (CVP) of 8–12 mmHg (or 12–15 mmHg in mechanically ventilated patients) to assess fluid responsiveness. 26
Ensure central venous oxygen saturation (ScvO₂) ≥ 70 % (or mixed venous O₂ saturation ≥ 65 %) to confirm sufficient tissue oxygen delivery. 26

Vasopressor Therapy

Norepinephrine should be started when MAP remains < 65 mmHg after the initial 30 mL/kg fluid bolus. 26
Vasopressin 0.03 U/min is added to norepinephrine when additional MAP support is required or to allow a lower norepinephrine dose. 26
Epinephrine is introduced if MAP targets cannot be achieved with the combination of norepinephrine and vasopressin. 26

Lactate Monitoring as a Resuscitation Endpoint

Obtain a baseline serum lactate measurement immediately at septic‑shock recognition. 26
Repeat lactate within six hours after the initial fluid resuscitation if the initial value is elevated, and use lactate trend toward normalization to guide ongoing resuscitation. 26

Ongoing Hemodynamic Assessment

Frequent reassessment of hemodynamics using clinical examination (heart rate, blood pressure, respiratory rate, temperature, urine output, mental status) and available monitoring is essential to evaluate response to therapy. 26

Septic Shock Management – Evidence‑Based Recommendations

Antimicrobial Therapy (First Hour)

Fluid Resuscitation (First 3 Hours)

Vasopressor Management (When MAP < 65 mmHg After Fluids)

Hemodynamic Targets (First 6 Hours)

Lactate Monitoring

Source Control (Within 12 Hours)

Antimicrobial Stewardship & De‑escalation

All statements are derived from peer‑reviewed evidence (Intensive Care Medicine 2017, Critical Care Medicine 2013, World Journal of Emergency Surgery 2017). No patient‑identifiable information is included.

Immediate Initiation of Norepinephrine in Septic Shock with Adequate Preload

Indications for Vasopressor Initiation

In adult patients with septic shock who have an adequate preload (central venous pressure ≈ 8 mm Hg) but persistent severe hypotension (mean arterial pressure ≈ 45 mm Hg) and signs of end‑organ hypoperfusion, norepinephrine should be started as the first‑line vasopressor. 30, 31
A central venous pressure of 8 mm Hg after initial fluid resuscitation indicates that the shock is primarily distributive rather than hypovolemic, necessitating vasopressor support. 30, 32

Norepinephrine Dosing and Hemodynamic Targets

Begin norepinephrine at 0.05–0.1 µg·kg⁻¹·min⁻¹ (≈ 5–10 µg·min⁻¹ for a 70‑kg adult). 30, 31
Aim for a MAP ≥ 65 mm Hg; values below this threshold compromise organ autoregulation and make perfusion pressure‑dependent. 30, 31
In patients with chronic hypertension, a higher MAP target of 70–75 mm Hg is recommended because their autoregulatory curve is shifted rightward. 30, 31

Assessment of Fluid Responsiveness

Perform a passive leg‑raise (PLR) test to evaluate preload responsiveness before giving additional fluid. 33, 32
If PLR produces an increase in MAP of ≥10 mm Hg or a decrease in heart rate, administer a 500 mL crystalloid bolus. 33, 32
Absence of a PLR response indicates preload‑independence; further fluid is unlikely to be beneficial and vasopressor/inotropic support should be prioritized. 33, 32
Approximately 50 % of postoperative hypotensive patients do not respond to extra fluid despite apparent hypovolemia. 33, 32

Monitoring and Titration of Norepinephrine

Do not rely solely on MAP; concurrently assess:
- Mental status – improvement in alertness and orientation. 31
- Urine output – maintain ≥0.5 mL·kg⁻¹·h⁻¹. 30, 31
- Skin perfusion – warm extremities and capillary refill < 2 s. 31
- Lactate clearance – obtain a baseline lactate and repeat at 2–6 h; a decreasing trend signals adequate resuscitation. 31

Second‑Line and Adjunct Vasopressors

If MAP remains < 65 mm Hg despite norepinephrine at 0.2–0.3 µg·kg⁻¹·min⁻¹ (≈ 15–20 µg·min⁻¹), add vasopressin at a fixed dose of 0.03 U·min⁻¹ to raise MAP or reduce norepinephrine requirements. 30, 31
Vasopressin should never be used as the sole initial vasopressor. 30, 31
If MAP is still inadequate after vasopressin, epinephrine may be introduced as a third‑line agent. 30, 31

Source Control and Antimicrobial Therapy

Prompt source control for intra‑abdominal sepsis is critical; obtain an emergent CT of the abdomen/pelvis to identify abscesses, anastomotic leaks, or perforations. 31
Administer broad‑spectrum intravenous antibiotics within 1 hour of shock recognition (e.g., piperacillin‑tazobactam or meropenem + metronidazole for intra‑abdominal infection). 31
Surgical consultation for drainage or re‑exploration should occur within 12 hours of shock onset. 31

Comparative Efficacy of Norepinephrine

Norepinephrine is more effective than dopamine for reversing hypotension in septic shock and is associated with fewer arrhythmic complications. 30
Its rapid MAP‑raising effect is mediated by arterial α₁‑adrenergic vasoconstriction. 30
Norepinephrine also increases mean systemic filling pressure via venous α‑adrenergic stimulation, thereby enhancing venous return and cardiac output. 34

Common Pitfalls and Mitigation Strategies

Excessive fluid administration when vasopressor support is required prolongs life‑threatening hypotension, risks fluid overload (especially in postoperative abdominal patients), and delays definitive therapy. 30, 31 for hypotension; 35, 34 for fluid overload.
Targeting a MAP of 65 mm Hg in chronic hypertensive patients may be insufficient; a higher target of 70–75 mm Hg should be used to ensure adequate organ perfusion. 30, 31
Cold‑shock physiology (cold, pale extremities with confusion) suggests high systemic vascular resistance with low cardiac output; if MAP improves with norepinephrine but perfusion remains poor, add dobutamine 2.5–5 µg·kg⁻¹·min⁻¹ to augment cardiac output. 30, 34
Undetected myocardial dysfunction can be identified with bedside echocardiography, guiding the need for inotropic support. 33, 32

Hemodynamic Resuscitation and Support in Septic Shock

Fluid Resuscitation (First 3 Hours)

Hemodynamic Targets (First 6 Hours)

Respiratory Support

Vasopressor and Inotropic Therapy

Adjunctive Therapies

Corticosteroids

Blood Product Management

All facts are derived from peer‑reviewed guidelines and studies cited in the original article.

Fluid Resuscitation Strategies and Monitoring

Hemodynamic Assessment During Early Resuscitation

In adult patients with hypotension, tachycardia, and elevated lactate, additional crystalloid boluses (250–500 mL over ~15 min) should be guided by dynamic indices such as pulse‑pressure variation or stroke‑volume variation, or by static variables including blood pressure, heart rate, and urine output, after the initial 30 mL/kg fluid challenge. 38

Prevention of Fluid Overload

During ongoing resuscitation, clinicians should vigilantly monitor for signs of fluid overload—elevated jugular venous pressure, rising respiratory rate, decreasing oxygen saturation, and pulmonary crackles—and reduce or stop fluid infusion when these appear to mitigate the risk of worsening shock and mortality. 38

Surviving Sepsis Campaign 2021 – Evidence‑Based Recommendations (Cited)

Corticosteroid Management

In adult patients with septic shock who achieve hemodynamic stability after adequate fluid resuscitation and vasopressor therapy, routine intravenous hydrocortisone is not recommended. 39
For patients whose hemodynamic stability cannot be attained despite adequate resuscitation, a weak recommendation is to administer hydrocortisone 200 mg per day (continuous infusion or divided doses). 39
ACTH stimulation testing should not be used to decide whether a septic‑shock patient receives hydrocortisone. 39
Hydrocortisone should be tapered once vasopressor support is no longer required. 39
In the absence of shock, corticosteroids are not indicated for sepsis alone. 39

Mechanical Ventilation for Sepsis‑Induced ARDS

For patients with sepsis‑related ARDS, use a tidal volume of 6 mL/kg predicted body weight (strong recommendation, grade 1A). 39
Maintain plateau pressures ≤ 30 cm H₂O in passively inflated lungs. 39
Apply positive end‑expiratory pressure (PEEP) to prevent alveolar collapse; employ higher PEEP strategies in moderate‑to‑severe ARDS. 39
Prone positioning is recommended for patients with a PaO₂/FiO₂ ratio ≤ 100 mmHg (or < 150 mmHg) when performed in centers experienced with the technique. 39
Keep the head‑of‑bed elevated 30–45° to lower the risk of ventilator‑associated pneumonia. 39

Blood Product Management

Red blood cell transfusion is indicated only when hemoglobin falls below 7.0 g/dL, with a target range of 7.0–9.0 g/dL (strong recommendation, grade 1B). 39
Higher transfusion thresholds may be used in active myocardial ischemia, severe hypoxemia, acute hemorrhage, or known ischemic heart disease. 39
Erythropoietin should not be used for anemia associated with sepsis. 39
Fresh‑frozen plasma is not recommended to correct laboratory coagulopathy unless the patient is bleeding or an invasive procedure is planned. 39
Prophylactic platelet transfusion: give when platelet count < 10,000/µL without bleeding; consider when < 20,000/µL with high bleeding risk; aim for ≥ 50,000/µL for active bleeding, surgery, or invasive procedures. 39

Interventions Not Recommended

Intravenous immunoglobulins should not be used routinely in sepsis. 39
Antithrombin therapy is not recommended for treatment of sepsis. 39

Cited Recommendations from the Surviving Sepsis Campaign 2021

Corticosteroid Management

The Surviving Sepsis Campaign 2021 advises that routine intravenous hydrocortisone should not be given to adult septic‑shock patients who have achieved hemodynamic stability with adequate fluids and vasopressors. 40, 41
A weak recommendation supports initiating intravenous hydrocortisone (200 mg/day) only when vasopressor requirements persist despite adequate resuscitation. 40, 41
ACTH stimulation testing should not be used to decide whether a septic‑shock patient receives hydrocortisone. 40, 41
Hydrocortisone should be tapered once vasopressor support is no longer needed. 40, 41
Corticosteroids are not indicated for sepsis in the absence of shock. 40, 41

Mechanical Ventilation for Sepsis‑Induced ARDS

Use a tidal volume of 6 mL/kg predicted body weight (strong recommendation, high‑quality evidence). 40, 42
Keep plateau pressures ≤30 cm H₂O in passively inflated lungs. 40, 42
Apply positive end‑expiratory pressure (PEEP), employing higher PEEP strategies for moderate‑to‑severe ARDS. 40, 42
Implement prone positioning in patients with a PaO₂/FiO₂ ratio ≤100 mmHg (or <150 mmHg) in centers experienced with the technique. 40, 42
Elevate the head‑of‑bed 30–45° to reduce the risk of ventilator‑associated pneumonia. 40, 42
Follow a weaning protocol that includes regular spontaneous breathing trials when patients are arousable, hemodynamically stable without vasopressors, free of new serious conditions, have low ventilatory requirements, and can tolerate low FiO₂ via mask or nasal cannula. 40, 42

Blood Product Management

Red‑blood‑cell transfusion is recommended only when hemoglobin falls below 7 g/dL, targeting a range of 7–9 g/dL (strong recommendation). 40, 41, 42
Higher hemoglobin thresholds are permissible in the setting of active myocardial ischemia, severe hypoxemia, acute hemorrhage, or known ischemic heart disease. 40, 41
Erythropoietin should not be used for anemia associated with sepsis. 40, 41, 42
Fresh‑frozen plasma should not be administered to correct laboratory coagulopathy unless there is active bleeding or an invasive procedure is planned. 40, 41, 42
Platelet transfusion: give prophylactically when platelet count <10,000 /mm³ without bleeding; consider transfusion when <20,000 /mm³ with high bleeding risk; aim for ≥50,000 /mm³ for active bleeding, surgery, or invasive procedures. 40, 41, 42

Interventions Not Recommended

Routine use of intravenous immunoglobulins in adult sepsis or septic‑shock patients is not recommended. 40, 41, 42
Antithrombin therapy for sepsis and septic shock is not recommended. 40, 41, 42
Pulmonary artery catheters should not be used routinely in patients with sepsis‑induced ARDS. 40, 42
β‑2 agonists are not recommended for treatment of sepsis‑induced ARDS unless specific indications such as bronchospasm are present. 40, 42

Early Resuscitation and Hemodynamic Management in Shock with Elevated Lactate

Fluid Resuscitation (First 3 Hours)

Administer at least 30 mL/kg of intravenous crystalloid within the first 3 hours to patients presenting with shock; this rapid volume expansion is the cornerstone of early therapy. 43
Deliver the initial 30 mL/kg as 500–1000 mL boluses over 5–10 minutes (≈2 L for a 70 kg adult) to achieve prompt intravascular filling. 43
Provide additional 250–500 mL crystalloid boluses over 15 minutes as needed, guided by real‑time signs of hemodynamic improvement (blood pressure, heart rate, urine output, mental status). 43

Immediate Diagnostic Work‑up

Obtain at least two sets of aerobic and anaerobic blood cultures before starting antibiotics, but do not postpone antimicrobial therapy for more than 45 minutes. 43
Measure serum lactate immediately on presentation and repeat it every 2–6 hours; aim for a lactate clearance of ≥10 % every 2 hours as an early indicator of treatment response. 43

Hemodynamic Targets (First 6 Hours)

Target a mean arterial pressure (MAP) of ≥65 mmHg in most patients during early resuscitation. 43
Maintain urine output of ≥0.5 mL/kg/hour as a bedside marker of adequate renal perfusion. 43
Aim for a central venous pressure (CVP) of 8–12 mmHg (or 12–15 mmHg in mechanically ventilated patients) to assess fluid responsiveness. 43
Achieve a central venous oxygen saturation (ScvO₂) of ≥70 % (or mixed venous O₂ saturation ≥65 %) to confirm sufficient tissue oxygen delivery. 43

Vasopressor Initiation and Escalation

Start vasopressor therapy when MAP remains <65 mmHg after the initial 30 mL/kg fluid bolus, without waiting for a predefined fluid volume. 43
Use norepinephrine as the first‑line vasopressor, beginning at 0.05–0.1 µg/kg/min (≈5–10 µg/min for a 70 kg adult) and titrate to maintain MAP ≥65 mmHg. 43
Add vasopressin at 0.03 U/min to norepinephrine when additional MAP support is required or to allow reduction of the norepinephrine dose; vasopressin should not be used as the sole initial agent. 43

Ongoing Monitoring

Perform serial lactate measurements every 2–6 hours throughout the acute resuscitation phase to objectively gauge response to therapy. 43
Reassess hemodynamic status frequently using clinical examination (heart rate, blood pressure, respiratory rate, temperature, urine output, mental status) to detect early deterioration or improvement. 43